Product image of Linezolid Pliva (Linezolid) supplied by GNH India

Linezolid Pliva

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Pliva (Linezolid)

Linezolid, the active ingredient in Linezolid Pliva, is an oxazolidinone antibiotic presented as an oral tablet for systemic use. It treats serious bacterial infections, including those caused by resistant Gram‑positive organisms, in adult patients. GNH India supplies Linezolid Pliva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Pliva Hrvatska D.O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid is an oxazolidinone antibiotic indicated for infections caused by susceptible bacteria.

  • Skin and soft tissue infections: eradicates methicillin‑resistant Staphylococcus aureus (MRSA) and other Gram‑positive pathogens in affected tissues.
  • Community‑acquired pneumonia: provides coverage against typical and atypical organisms, including resistant strains.
  • Nosocomial pneumonia: treats hospital‑acquired lower respiratory infections caused by susceptible organisms.
  • MRSA infections: offers an effective oral option for confirmed MRSA infections when other agents are unsuitable.

How It Works

  • Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing formation of the initiation complex and thereby halting translation. This action is bacteriostatic against most susceptible organisms and bactericidal at higher concentrations, targeting Gram‑positive bacteria including resistant strains.

Side Effects

Linezolid may cause a range of adverse reactions, most of which are dose‑independent.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: loose stools occurring during therapy.
  • Headache: transient cranial discomfort.
  • Metallic taste: altered taste perception.
  • Myelosuppression: reduction in blood cell counts, especially with prolonged use.
  • Peripheral neuropathy: tingling or numbness in extremities.

Serious or Rare Side Effects

  • Serotonin syndrome: risk when combined with serotonergic agents.
  • Lactic acidosis: metabolic disturbance requiring immediate attention.
  • Severe thrombocytopenia: markedly low platelet counts.
  • Optic neuritis: visual disturbances and potential vision loss.
  • Hepatotoxicity: elevated liver enzymes indicating liver injury.
  • Hypersensitivity reactions: rash, fever, or anaphylaxis.

Precautions & Warnings

Before prescribing Linezolid, clinicians should consider several safety aspects.

  • Renal impairment: adjust therapy and monitor renal function.
  • Hepatic dysfunction: assess liver enzymes and use with caution.
  • Hematologic monitoring: perform regular complete blood counts during prolonged treatment.
  • Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome.
  • Pregnancy and lactation: evaluate risk‑benefit ratio; limited data available.
  • Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Avoid Interactions

Linezolid interacts with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic agents: may precipitate serotonin syndrome.
  • Monoamine oxidase inhibitors (MAOIs): increase risk of hypertensive crisis.
  • Tyramine‑rich foods: can exacerbate hypertensive reactions when combined with MAOIs.

Moderate Interactions (Monitor Closely)

  • Rifampicin: may reduce linezolid plasma concentrations.
  • Warfarin: potential for enhanced anticoagulant effect; monitor INR.
  • Ethanol: may increase the risk of hypotension.
  • CNS depressants: additive sedation possible.
  • Antacids containing magnesium or aluminum: may affect absorption; separate administration times.

Frequently Asked Questions

Linezolid Pliva is indicated for serious bacterial infections caused by susceptible Gram‑positive organisms, including skin and soft tissue infections, community‑acquired and nosocomial pneumonia, and infections due to methicillin‑resistant Staphylococcus aureus (MRSA).

Linezolid binds to the 50S subunit of bacterial ribosomes, blocking the formation of the initiation complex required for protein synthesis. This inhibition stops bacterial growth and can be bacteriostatic or bactericidal depending on the organism and drug concentration.

The dosage of Linezolid Pliva is determined by the prescribing clinician based on the specific infection, patient characteristics, and local guidelines. Only a qualified healthcare professional should set the dose and duration of therapy.

Safety data for Linezolid in pregnancy and lactation are limited. Clinicians should weigh the potential benefits against possible risks and consider alternative therapies when appropriate. Consultation with a specialist is recommended.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Linezolid offers oral bioavailability and activity against MRSA, making it a convenient alternative to intravenous agents like vancomycin. It is particularly useful when oral therapy is preferred or when patients cannot tolerate other options, though cost and side‑effect profile differ.

Linezolid Pliva should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat and direct sunlight to maintain stability.

Linezolid Pliva is taken orally, usually as a tablet, with or without food. The exact administration instructions, including timing and any required food considerations, are provided by the prescribing healthcare professional.

Serious risks include serotonin syndrome when combined with serotonergic drugs, severe myelosuppression such as thrombocytopenia, lactic acidosis, optic neuritis, and rare hypersensitivity reactions. Patients should be monitored closely for these events.

Linezolid Pliva is contraindicated in patients with known hypersensitivity to linezolid or any component of the formulation, and should be used with caution in individuals taking serotonergic agents, MAO inhibitors, or those with significant hepatic or renal impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT